Kathmere Capital Management’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-844
Closed -$225K – 699
2026
Q1
$225K Buy
+844
New +$229K 0.01% 548
2025
Q4
– Sell
-720
Closed -$207K – 586
2025
Q3
$207K Buy
+720
New +$193K 0.01% 489

Other funds holding LH

Kathmere Capital Management's LH Position: Q2 2026 in Review

Kathmere Capital Management sold out of Labcorp (LH) in Q2 2026, closing a stake of 844 shares — an estimated $225K sold.

Kathmere Capital Management first reported a position in LH in Q3 2025 and held it in 2 quarters. The position peaked at $225K in Q1 2026. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • Kathmere Capital Management reported no remaining Labcorp position as of Q2 2026 after selling out during the quarter.
  • Kathmere Capital Management sold 844 Labcorp shares in Q2 2026, an estimated $225K.
  • Kathmere Capital Management first reported a position in Labcorp in Q3 2025 and held it in 2 quarters.
  • Kathmere Capital Management's Labcorp position peaked at $225K in Q1 2026.
  • 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on Kathmere Capital Management's 13F filing for Q2 2026, filed 29 Jul 2026.